|
|
||||||||
BRIEF REVIEWS |

* BioTherapeutics Research Group, Robarts Research Institute, and Departments of Microbiology and Immunology, and
Medicine, University of Western Ontario, London, Ontario, Canada
Many viruses have learned to evade or subvert the host antiviral immune responses by encoding and expressing immunomodulatory proteins that protect the virus from attack by elements of the innate and acquired immune systems. Some of these viral anti-immune regulators are expressed as secreted proteins that engage specific host immune targets in the extracellular environment, where they exhibit potent anti-immune properties. We review here viral immunomodulatory proteins that have been tested as anti-inflammatory reagents in animal models of disease caused by excessive inflammation or hyperactivated immune pathways. The potential for such viral molecules for the development of novel drugs to treat immune-based or inflammatory disorders is discussed.
This article has been cited by other articles:
![]() |
M. Deruaz, A. Frauenschuh, A. L. Alessandri, J. M. Dias, F. M. Coelho, R. C. Russo, B. R. Ferreira, G. J. Graham, J. P. Shaw, T. N.C. Wells, et al. Ticks produce highly selective chemokine binding proteins with antiinflammatory activity J. Exp. Med., September 1, 2008; 205(9): 2019 - 2031. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Ruiz-Arguello, V. P. Smith, G. S. V. Campanella, F. Baleux, F. Arenzana-Seisdedos, A. D. Luster, and A. Alcami An Ectromelia Virus Protein That Interacts with Chemokines through Their Glycosaminoglycan Binding Domain J. Virol., January 15, 2008; 82(2): 917 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Domingo-Gil, E. Perez-Jimenez, I. Ventoso, J. L. Najera, and M. Esteban Expression of the E3L Gene of Vaccinia Virus in Transgenic Mice Decreases Host Resistance to Vaccinia Virus and Leishmania major Infections J. Virol., January 1, 2008; 82(1): 254 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Lucas, R. Korol, and C. J. Pepine Inflammation in Atherosclerosis: Some Thoughts About Acute Coronary Syndromes Circulation, May 2, 2006; 113(17): e728 - e732. [Full Text] [PDF] |
||||
![]() |
S. Ranjbar, R. Rajsbaum, and A. E. Goldfeld Transactivator of Transcription from HIV Type 1 Subtype E Selectively Inhibits TNF Gene Expression via Interference with Chromatin Remodeling of the TNF Locus J. Immunol., April 1, 2006; 176(7): 4182 - 4190. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dai, K. Viswanathan, Y. M. Sun, X. Li, L. Y. Liu, B. Togonu-Bickersteth, J. Richardson, C. Macaulay, P. Nash, P. Turner, et al. Identification of Myxomaviral Serpin Reactive Site Loop Sequences That Regulate Innate Immune Responses J. Biol. Chem., March 24, 2006; 281(12): 8041 - 8050. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kim and Y. Kliger Discovering hidden viral piracy Bioinformatics, December 1, 2005; 21(23): 4216 - 4222. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Fielding, R. M. McLoughlin, C. S. Colmont, M. Kovaleva, D. A. Harris, S. Rose-John, N. Topley, and S. A. Jones Viral IL-6 Blocks Neutrophil Infiltration during Acute Inflammation J. Immunol., September 15, 2005; 175(6): 4024 - 4029. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |